Abbott Acute Cardiac Tests
Abbott Completes Acute Cardiac Panel for ARCHITECT® System with Addition of Myoglobin Assay, making the cardiac panel available on two platforms — ARCHITECT and AxSYM.
With ARCHITECT's acute cardiac menu and stat functionality, laboratories can process cardiac tests quickly and efficiently, supplying doctors with the results they need to diagnose and treat patients with chest pain.
ARCHITECT® STAT Myoglobin test complements other ARCHITECT cardiac assays and assists in the early diagnosis of a heart attack.
ABBOTT ACUTE CARDIAC TESTS
"Each cardiac biomarker serves a different clinical role and provides doctors with important information to assess and treat patients with chest pain. By offering a complete acute cardiac panel for ARCHITECT, laboratories can take advantage of the automation, multidimensional sampling and stat capabilities the instrument provides and turn around cardiac test results quickly," said William Brown, Ph.D., Vice President, Diagnostics Assays and Systems Development, Abbott.
ARCHITECT i2000SR & ci8200
STAT Troponin-I
Information Sheet [pdf]
Providing stat results with 15.8 minutes, the ARCHITECT i2000SR is an automated immunoassay system that can perform up to 200 tests per hour. The stat functionality enables rapid turnaround time of TnI results enabling doctors to quickly diagnose and treat patients with chest pain.
ARCHITECT® STAT CK-MB has good clinical performance meeting today’s standards of care.
- The assay is standardized to the AACC recommended standard
- Meets ACC/ESC Performance Guidelines
- Good precision across the assay range
AxSYM
Abbott provides one of the most comprehensive cardiac menus for the acute care hospital laboratory by offering diagnostics tests that assist in determining a patient’s overall cardiac health.
Troponin-I ADV
Information Sheet [pdf]
AxSYM Troponin-I ADV offers enhanced performance and standardized results to better meet evolving standards of paient care. AxSYM Troponin-I ADV provides initial results within 15 minutes and offers improved detection of cardiac troponin–a protien that is released from dying heart muscle cells deprived of blood flow during a heart attack.
CK-MB
- Diagnosis of AMI – rule in/rule out
- Relative Index with total CK often used to increase specificity
- Confirmation of reperfusion
- Risk stratification
- CK-MB can detect prolonged ischemia in unstable angina patients
Myoglobin levels start to rise as early as two to four hours following a heart attack and reach their highest levels within eight to twelve hours before returning back to normal after 24 hours. Monitoring myoglobin levels in combination with an electrocardiogram (ECG) can help evaluate the success of thrombolytic therapy where a drug is administered to break up or dissolve blood clots, often the main cause of a heart attack.
A document linked on this page is in PDF format.
A
free reader is available here via Adobe Systems.
